Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company focused on research and development of signal transduction research reagents including primary phospho-specific antibodies, ELISA kits, and recombinant proteins.
Affinity Biosciences focuses on providing high-quality antibodies that target key cell signaling pathways including apoptosis, autophagy, cancer biology, and immunology research. Every antibody is rigorously validated via Western Blot, IHC, and IF applications.